Navigation Links
The American Society of Hematology announces awards honoring abstracts at 2011 Annual Meeting

WASHINGTON The American Society of Hematology (ASH) recognizes the following abstract presenters at the 53rd ASH annual meeting in San Diego, CA, with the highest scoring abstracts in the categories of undergraduate student, medical student, graduate student, resident physician, and postdoctoral fellow. Outstanding Abstract Achievement Award (formerly Merit Award) winners receive a $500 honorarium plus annual meeting travel reimbursement.

The 2011 Outstanding Abstract Achievement Award recipients are:

Undergraduate Student
Kathryn Luk
University of Minnesota, Minneapolis, MN
Association of Mu Opioid Receptor with Neurogenic Inflammation in Sickle Mice
Abstract #895

Medical Student
Morgan Jones
University of Michigan, Ann Arbor, MI
The Trithorax Group Protein Ash1l Is An Essential Epigenetic Regulator of Adult Hematopoietic Stem Cell Maintenance
Abstract #387

Alison Schram
Memorial Sloan-Kettering Cancer Center, New York, NY
Genetic and Functional Investigation of Germline JAK2 Alleles That Predispose to Myeloproliferative Neoplasms
Abstract #124

Graduate Student
Jin Yuan
Graduate School of Medicine, Chiba University, Chiba, Japan
Lethal Myelofibrosis Induced by Bmi1-Deficient Hematopoietic Cells Unveils a Tumor Suppressor Function of the Polycomb Group Genes
Abstract #390

Resident Physician
Christian Braun, MD
University Children's Hospital, Dr. von Haunersches Kinderspital, Munich, Germany
Efficacy of Gene Therapy for Wiskott-Aldrich-Syndrome
Abstract #165

Postdoctoral Fellow
Kathryn Roberts, PhD
St. Jude Children's Research Hospital, Nashville, TN
Novel Chromosomal Rearrangements and Sequence Mutations in High-Risk Ph-Like Acute Lymphoblastic Leukemia
Abstract #67

Mary Rodes Gibson Memorial Award in Hemostasis and Thrombosis
This award was established to recognize the trainee (undergraduate student, medical student, graduate student, resident physician, or postdoctoral fellow) who is the first author and presenter of the highest scoring abstract submitted in the field of hemostasis and thrombosis. This annual award is made possible by the Mary Rodes Gibson Hemostasis-Thrombosis Foundation to continue the legacy of Mary Rodes Gibson, who suffered from severe, type 3 von Willebrand disease.

The 2011 recipient is:
Sou Nakamura
Center for IPS Cell Research and Application at Kyoto University, Kyoto, Japan
Platelet Production System Using An Immortalized Megakaryocyte Cell Line Derived From Human Pluripotent Stem Cells
Abstract #2

Minority Graduate Student Abstract Achievement Award
The Minority Graduate Student Abstract Achievement Award was established in 2011 with the goal of attracting and/or retaining minority PhD students to the field of hematology through the ASH annual meeting.

The inaugural recipients of this award are:

Patrice Capers
Morehouse School of Medicine, Atlanta, GA
What's Your Tanner? An Analysis of the Impact of Sickle Cell Disease Phenotype on Pubertal Development and Body Mass
Abstract #2123

Nyasha Chambwe
Weill Cornell Medical College, New York, NY
Epigenetic Profiling of Primary DLBCLs Reveals Novel DNA Methylation-Based Clusters and New Underlying Mechanisms of Lymphomagenesis
Abstract #556

Grace I. Aldana Masangkay
University of California, Los Angeles, CA
A Small Molecule Inhibitor Targeting CREB and CBP Inhibits Proliferation of AML Cells In Vitro and In Vivo
Abstract #3607

Marthe-Sandrine Eiymo Mwa Mpollo
University of Cincinnati, Cincinatti, OH
Sickle Cell Disease Is Associated with Reduced Adenosine Deaminase Catalytic Activity, Resulting in Altered Adenosine Metabolism
Abstract #1078

Muithi Mwanthi
Indiana University School of Medicine, Bloomington, IN
PAK1 Regulates Eotaxin-Mediated Murine Eosinophil Migration in Vitro and In Vivo
Abstract #18

D'Andra Parker
McMaster University, Hamilton, Ontario, Canada
Characterization of the Binding Between the Polymeric Platelet Adhesive Proteins, Multimerin 1 and Von Willebrand Factor
Abstract #1144

Colles Orrin Joseph Price
University of Chicago, Chicago, IL
MLL-Rearrangements Result in Upregulation of Mir-9 and Subsequent Inhibition of the Tumor Suppressor TGFBI
Abstract #2453

National Marrow Donor Program Award for Best Abstracts
To commemorate the National Marrow Donor Program's (NMDP) 25th anniversary and to honor the program's facilitation of 50,000 transplants, ASH and NMDP have partnered in 2011 to provide ten $2,500 awards to the highest scoring abstract in the following categories:

  • Clinical Allogeneic and Autologous Transplantation: Results
  • Bone Marrow Failure
  • Acute Lymphoblastic Leukemia: Biology & Pathophysiology
  • Acute Myeloid Leukemia: Biology & Pathophysiology
  • Non-Hodgkin Lymphoma: Biology, excluding Therapy
  • Myelodysplastic Syndromes
  • Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities
  • Clinical Allogeneic Transplantation: Acute and Chronic Graft-Versus-Host Disease and Immune Reconstitution
  • Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence
  • Health Services and Outcomes Research

Contact: Lindsey Love
American Society of Hematology

Related medicine news :

1. BMC resident receives American Society for Clinical Pathology awards
2. Younger Americans Face Greater Health Disparities: Study
3. American Diabetes Associations preferred testing method fails to identify kids with diabetes
4. More Americans Living to 90, U.S. Census Finds
5. Poorer Americans See Sharper Health Declines With Age
6. Leading North American institutions endorse the Berlin Declaration on Open Access to Knowledge
7. Community leaders honored for helping Americans most in need
8. Older Americans Encouraged to Get Fit
9. Scott & White Healthcare and American Cancer Society enter into partnership for prevention study
10. Gene variant increases risk of kidney disease in African-Americans
11. More African-Americans burdened by osteoarthritis in multiple large joints
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: